Search Results - "Reinhardt, Brian J."

Pre-clinical drug-drug interactions (DDIs) of gefitinib with/without losartan and selective serotonin reuptake inhibitors (SSRIs): citalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, and venlafaxine by Luong, Thu-Lan T., Powers, Chelsea N., Reinhardt, Brian J., Weina, Peter J.

“…To evaluate drug-drug interactions (DDIs) between gefitinib with/without losartan and selective serotonin reuptake inhibitors (SSRIs). In vitro supersomes were…”
Get full text

Pre-clinical drug-drug interaction (DDI) of gefitinib or erlotinib with Cytochrome P450 (CYP) inhibiting drugs, fluoxetine and/or losartan by Luong, Thu-Lan T., McAnulty, Michael J., Evers, David L., Reinhardt, Brian J., Weina, Peter J.

“…[Display omitted] •In vitro drug-drug interactions (DDIs) can predict drug combination outcomes.•Cytochrome (CYP) P450 and hepatocytes are able to confirm…”
Get full text

Catecholamine responses to virtual combat: implications for post-traumatic stress and dimensions of functioning by Highland, Krista B, Costanzo, Michelle E, Jovanovic, Tanja, Norrholm, Seth D, Ndiongue, Rochelle B, Reinhardt, Brian J, Rothbaum, Barbara, Rizzo, Albert A, Roy, Michael J

“…Posttraumatic stress disorder (PTSD) symptoms can result in functional impairment among service members (SMs), even in those without a clinical diagnosis. The…”
Get full text

Swallowed glucocorticoid therapy for eosinophilic esophagitis in children does not suppress adrenal function by Philla, Katherine Q, Min, Steve B, Hefner, Jody N, Howard, Robin S, Reinhardt, Brian J, Nazareno, Luz G, Vogt, Karen S

“…The purpose of this study was to examine the effect of chronic swallowed glucocorticoids on adrenal function during the treatment of eosinophilic esophagitis…”
Get more information

Paclitaxel Drug-Drug Interactions in the Military Health System by Luong, Thu-Lan T, Shou, Karen J, Reinhardt, Brian J, Kigelman, Oskar F, Greenfield, Kimberly M

“…Paclitaxel is an antineoplastic agent used to treat breast, lung, endometrial, cervical, pancreatic, sarcoma, and thymoma cancer. However, drugs that induce,…”
Get full text

Retrospective evaluation of drug to drug interactions with paclitaxel use in military health by Kigelman, Oskar, Luong, Thu-Lan T., Shou, Karen J., Reinhardt, Brian J., Greenfield, Kimberly

“…e24118 Background: Paclitaxel is an antineoplastic agent used in the management of multiple metastatic and non-resectable tumor types approved for ovarian,…”
Get full text

Retrospective evaluation of erlotinib and gefitinib used in the military health system from the perspective of drug-drug interactions by Shou, Karen J, Luong, Thu-Lan T., Powers, Chelsea N., Reinhardt, Brian J., McAnulty, Mike J., Weina, Peter J.

“…e15108 Background: Erlotinib and gefitinib are epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) approved primarily for non-small cell…”
Get full text

Retrospective Evaluation of Drug-Drug Interactions With Erlotinib and Gefitinib Use in the Military Health System by Luong, Thu-Lan T, Powers, Chelsea N, Reinhardt, Brian J, McAnulty, Michael J, Weina, Peter J, Shou, Karen J, Ambar, Caban B

“…BackgroundErlotinib and gefitinib are epidermal growth factor receptor-tyrosine kinase inhibitors approved for non-small cell lung cancer treatment by the US…”
Get full text